Biomea Fusion, Inc. (BMEA)

Biomea Fusion, Inc. (BMEA) is a healthcare company (biotechnology) based in the United States. The share price is $0.49, down 6.17% on the day, which values the company at $35.47M. Price as of 18 Nov 2026, 12:18 UTC, from Yahoo Finance.

Key facts

Share price
$0.49−6.17% today
Market value
$35.47M
200-week average
$8.1994% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Biomea Fusion, Inc. in more detail

BMEA trades at -0.6× next year's expected earnings. It sits 94% below its 200-week average of $8.19.

In its favour: More cash than debt. Worth checking: Weak Piotroski score; Share count keeps rising.

Biomea Fusion, Inc. (BMEA): questions and answers

What is Biomea Fusion, Inc.'s market cap?

Biomea Fusion, Inc. is valued at $35.47M at a share price of $0.49.

Is BMEA above its 200-week moving average?

No. BMEA is 94.0% below its 200-week average of $8.19. Long-term investors watch that line because strong companies rarely trade below it for long.

Does BMEA pay a dividend?

Biomea Fusion, Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Biomea Fusion, Inc. (BMEA) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/BMEA

Underlying data: Yahoo Finance; company filings with the SEC.